{"entity":{"type":"insider","cik":"0001589565","url":"/insider/0001589565","json_url":"/insider/0001589565.json","name":"Begley Colin Glenn","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":10,"n_filings":4,"first":"2014-11-28","last":"2015-02-17","span_basis":"filed_date"},"name_variants":[{"name":"Begley Colin Glenn","source":"filing","n_filings":4,"first_seen":"2014-11-28","last_seen":"2015-02-17"}],"transactions":[{"id":9238084,"accession":"0001171843-15-000870","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001171843-15-000870","line_url":"/filing/0001171843-15-000870#line-1","is_derivative":false,"issuer_cik":"0001361248","issuer_name":"TETRALOGIC PHARMACEUTICALS CORP","issuer_ticker":"TLOG","issuer_name_source":null,"issuer_url":"/issuer/0001361248","owner_cik":"0001589565","owner_name":"Begley Colin Glenn","owner_display_name":"Begley Colin Glenn","owner_url":"/insider/0001589565","role":"Officer (Chief Scientific Officer & SVP)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer & SVP)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer & SVP","security_title":"Common Stock - Colin Glenn Begley","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6000.0,"shares_display":"6,000","price_per_share":6.16,"price_display":"6.16","price_state":"stated","total_value":36960.0,"total_display":"36,960.00","total_whole":"36,960","shares_owned_after":198234.0,"shares_owned_after_display":"198,234","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-12-10","filed_date":"2015-02-17","scope":"insider"},{"id":6379140,"accession":"0001171843-14-005877","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001171843-14-005877","line_url":"/filing/0001171843-14-005877#line-1","is_derivative":false,"issuer_cik":"0001361248","issuer_name":"TETRALOGIC PHARMACEUTICALS CORP","issuer_ticker":"TLOG","issuer_name_source":null,"issuer_url":"/issuer/0001361248","owner_cik":"0001589565","owner_name":"Begley Colin Glenn","owner_display_name":"Begley Colin Glenn","owner_url":"/insider/0001589565","role":"Officer (Chief Scientific Officer & SVP)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer & SVP)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer & SVP","security_title":"Common Stock - Colin Glenn Begley","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5900.0,"shares_display":"5,900","price_per_share":6.16,"price_display":"6.16","price_state":"stated","total_value":36344.0,"total_display":"36,344.00","total_whole":"36,344","shares_owned_after":198134.0,"shares_owned_after_display":"198,134","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-12-10","filed_date":"2014-12-12","scope":"insider"},{"id":6934181,"accession":"0001171843-14-005738","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001171843-14-005738","line_url":"/filing/0001171843-14-005738","is_derivative":false,"issuer_cik":"0001361248","issuer_name":"TETRALOGIC PHARMACEUTICALS CORP","issuer_ticker":"TLOG","issuer_name_source":null,"issuer_url":"/issuer/0001361248","owner_cik":"0001589565","owner_name":"Begley Colin Glenn","owner_display_name":"Begley Colin Glenn","owner_url":"/insider/0001589565","role":"Officer (Chief Scientific Officer & SVP)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer & SVP)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer & SVP","security_title":"Common Stock, Ryan Alexander Begley (Son)","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3100.0,"shares_display":"3,100","price_per_share":4.858690322580645,"price_display":"4.86","price_state":"stated","total_value":15061.94,"total_display":"15,061.94","total_whole":"15,062","shares_owned_after":1100.0,"shares_owned_after_display":"1,100","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-11-26","filed_date":"2014-12-01","scope":"insider","n_lines":3},{"id":6958543,"accession":"0001171843-14-005719","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001171843-14-005719","line_url":"/filing/0001171843-14-005719","is_derivative":false,"issuer_cik":"0001361248","issuer_name":"TETRALOGIC PHARMACEUTICALS CORP","issuer_ticker":"TLOG","issuer_name_source":null,"issuer_url":"/issuer/0001361248","owner_cik":"0001589565","owner_name":"Begley Colin Glenn","owner_display_name":"Begley Colin Glenn","owner_url":"/insider/0001589565","role":"Officer (Chief Scientific Officer & SVP)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer & SVP)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer & SVP","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":4.853465,"price_display":"4.85","price_state":"stated","total_value":9706.93,"total_display":"9,706.93","total_whole":"9,707","shares_owned_after":188934.0,"shares_owned_after_display":"188,934","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-11-25","filed_date":"2014-11-28","scope":"insider","n_lines":5}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":10,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":10,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":10},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001361248","name":"TETRALOGIC PHARMACEUTICALS CORP","url":"/issuer/0001361248","role":"Officer (Chief Scientific Officer & SVP)","n_filings":4,"first_seen":"2014-11-28","last_seen":"2015-02-17"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001589565","retrieved_at":"2026-08-26T03:53:13+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}